New hope for tough blood cancers: trial tests promising drug combo

NCT ID NCT04588922

Recruiting now Disease control Sponsor: Sellas Life Sciences Group Source: ClinicalTrials.gov ↗

Summary

This study is testing a new drug called SLS009 for people with advanced blood cancers that have come back or stopped responding to treatment, and for newly diagnosed patients with high-risk forms of leukemia. The main goals are to find a safe dose and see if the drug, given alone or with other standard medications, can help control the cancer. It is enrolling adults and some teenagers with specific types of leukemia or lymphoma.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Affiliated Cancer Hospital of Chongqing University
WITHDRAWN

Chongqing, Chongqing Municipality, China
Affiliated Hospital of Hebei University
COMPLETED

Baoding, Hebei, China
Anhui Provincial Hospital
COMPLETED

Hefei, Anhui, China
Baylor Scott & White Health
RECRUITING

Dallas, Texas, 75246, United States

Contact
Blood disease hospital, Chinese Academy of Medical Science
COMPLETED

Tianjin, Tianjin Municipality, 300000, China
Bon Secours St. Francis Cancer Center
RECRUITING

Greenville, South Carolina, 29607, United States

Contact
Cancer prevention and treatment center of Sun Yat sen University
COMPLETED

Guangzhou, Guangdong, China
Clinical Research Alliance, Inc.
TERMINATED

Lake Success, New York, 11042, United States
Guangdong Provincial People's Hospital
COMPLETED

Guangzhou, Guangdong, China
Henan Cancer Hospital
COMPLETED

Zhengzhou, Henan, 450000, China
Linyi Cancer Hospital
COMPLETED

Linyi, Shandong, China
MD Anderson
RECRUITING

Houston, Texas, 77091, United States

Contact
New York - Presbyterian Hospital
TERMINATED

New York, New York, 10032, United States
O'Neal Comprehensive Cancer Center, University of Alabama
RECRUITING

Birmingham, Alabama, 35233, United States

Contact
Ochsner Clinic Foundation
TERMINATED

New Orleans, Louisiana, 70121, United States
Shengjing Hospital Affiliated to China Medical University
COMPLETED

Shenyang, Liaoning, China
The First Affiliated Hospital Of Nanchang University
COMPLETED

Nanchang, Jiangxi, China
The First Affiliated Hospital of Bengbu Medical College
COMPLETED

Bengbu, Anhui, China
The First Affiliated Hospital of Soochow University
COMPLETED

Suzhou, Jiangsu, China
The Second Affiliated hospital of Zhejiang University School of Medicine
COMPLETED

Hangzhou, Zhejiang, 310000, China
UNC School of Medicine, Division of Hematology
RECRUITING

Chapel Hill, North Carolina, 27599, United States

Contact

Conditions

Explore the condition pages connected to this study.

HEMATOLOGIC MALIGNANCIES